Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
The method of any one of Priority Applications (1) Applications Claiming Priority (4) Publications (1) Family ID=68295714 Family Applications (1) Country Status (3) Cited By (2) Families Citing this family (6) Family Cites Families (4) 2019 2019-04-25 EP EP19793176.9A patent/EP3810146A4/en not_active Withdrawn 2019-04-25 US US17/050,421 patent/US20210186943A1/en not_active Abandoned 2019-04-25 WO PCT/US2019/029231 patent/WO2019210107A1/en not_active Ceased
Being overweight or obese can lead to a number of health complications and exacerbate the risk of more negative health outcomes when another condition arises
Final Thoughts: Nutrition Can Help, But Not Replace Peptide Therapies Injectable peptides like PT-141 and BPC-157 offer fast, targeted results
Patients with obesity-related and T2 low asthma with or without type 2 diabetes mellitus (T2DM) experience worse clinical outcomes, including more severe acute exacerbations
The overlapping constipation risk deserves particular attention because severe constipation is one of the most common reasons people discontinue GLP-1 receptor agonists
